Parathyroid hyperplasia: an unusual cause of neonatal hypercalcemia

M S Payne1, D L Suskind, A Vargas

  • 1Children's Hospital of New Orleans, LSU Health Sciences Center, Division of Otolaryngology, 200 Henry Clay Ave, New Orleans LA 70118, USA.

Insights

Primary hyperparathyroidism in infants, a condition of parathyroid hyperplasia, causes severe hypercalcemia. Surgical removal of the parathyroid gland offers a successful treatment for affected infants.

Area of Science:

  • Pediatric Endocrinology
  • Surgical Oncology
  • Genetics

Background:

  • Primary hyperparathyroidism (PHPT) in infants is a rare condition characterized by parathyroid chief cell hyperplasia.
  • PHPT presents with severe chronic hypercalcemia, leading to failure to thrive, irritability, abdominal pain, and anorexia.
  • Medical management for infant PHPT is often ineffective, carrying significant risks of mortality or persistent hypercalcemia.

Observation:

  • A 7-month-old infant presented with symptoms consistent with severe chronic hypercalcemia due to PHPT.
  • The infant's condition was attributed to parathyroid chief cell hyperplasia.
  • Conservative medical therapies proved inadequate for managing the infant's hypercalcemia.

Findings:

  • Subtotal parathyroidectomy was performed on the infant.
  • The surgical intervention successfully resolved the chronic hypercalcemia.
  • Histopathological examination confirmed parathyroid chief cell hyperplasia as the underlying cause.

Implications:

  • Surgical intervention, specifically subtotal parathyroidectomy, is a viable and effective treatment for PHPT in infants.
  • Early surgical management can prevent severe complications associated with chronic hypercalcemia in infants.
  • This case highlights the importance of considering surgical options for PHPT when medical management fails in pediatric patients.

Related Concept Videos

Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Cellular Adaptation III: Hyperplasia01:26

Cellular Adaptation III: Hyperplasia

Hyperplasia is an increase in the number of cells in a tissue or organ due to enhanced cell division. It is an adaptive, controlled response to stimuli such as injury, hormones, or stress, involving mitosis to produce genetically identical cells and support tissue repair and regeneration.Tissue CapacityCertain tissues, including the epidermis, intestinal epithelium, bone marrow, and fibroblasts, have a high potential for hyperplasia. Others, such as bone, cartilage, and smooth muscle, show...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...